Global Assisted reproductive technology Market

Assisted Reproductive Technology Market Size, Share, Growth Analysis, By Product(Instrument, Accessory & Disposable and Reagents & Media), By Technology(In Vitro-Fertilization, Artificial Insemination and Others), By End User(Fertility Clinic, Hospital, Surgical Center and Clinical Research Institute), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35G2228 | Region: Global | Published Date: July, 2024
Pages: 165 | Tables: 91 | Figures: 76

Assisted Reproductive Technology Market Regional Insights

Owing to its massive investments in health care administration, expanding human population and increasing infertility cases, the Asia-Pacific region is the kingpin of the global assisted reproductive technology market. Countries such as China and India are in need of assisted reproductive technologies (ART) because of changing social norms, rising awareness levels and easier access to modern reproductive technology. The region also gains from increased government funding, changing laws and policies, and an increase in fertility clinics providing state-of-the-art care. These elements coming together, combined with enhanced healthcare systems and economic growth, puts Asia-Pacific as a prominent market for ART, spurring its innovation and growth. 

In Europe, the marketplace for assisted reproductive technology (ART) is growing faster than anywhere else in the world owing to its robust healthcare system, progressive legislation and high demand for fertility treatment. This region enjoys significant public backing and awareness, huge amounts of research and development as well as sophisticated ART technologies. The market has expanded due to improved access to fertility clinics, supportive laws on ART and insurance cover for such procedures. This demand also arises from Europe’s aging population coupled with increasing infertility rates while technological advancements aimed at personalizing medicine are contributing to rapid growth within this industry. 

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Assisted Reproductive Technology Market size was valued at USD 25.30 Billion in 2022 poised to grow from USD 26.67 Billion in 2023 to USD 40.67 Billion by 2031, growing at a CAGR of 5.40% in the forecast period (2024-2031). 

Global aided reproductive technology (ART) market is highly competitive as major companies pursue innovative solutions through advanced technologies. Key players include CooperSurgical who offers a variety of ART products, IVF Technologies which was the first to develop ART techniques and Ferring Pharmaceuticals widely recognized for its fertility drugs. To improve success rates and meet increasing demand for ART worldwide, these companies are engaged in R&D activities, forming alliances and expanding their services.  'Ferring Pharmaceuticals (Switzerland) ', 'CooperSurgical, Inc. (US) ', 'IVF Technologies (USA) ', 'Merck KGaA (Germany) ', 'Genea Biomedx (Australia) ', 'Hamilton Thorne Ltd. (Canada) ', 'Vitrolife AB (Sweden) ', 'LABORIE (Canada) ', 'ESN (France) ', 'MedTec (USA) ', 'CryoLife, Inc. (USA) ', 'Nantong Egens Biotechnology Co., Ltd. (China) ', 'Research Instruments Ltd. (UK) ', 'Sartorius AG (Germany) ', 'Thermo Fisher Scientific Inc. (USA) '

Infertility rates are increasing due to factors such as late childbearing, changes in lifestyle and environmental interactions; hence ART becomes very crucial. More and more couples want to solve their infertility problems, resulting in more demand for these services leading to increased growth of this industry. 

Expansion of Personalized ART Solutions: Due to advancements made in genetic screening and embryo analysis, the market is increasingly tilting in favor of individualized ART therapies. These tailored approaches aim at enhancing success rates and producing more efficient and focused fertility treatments by tackling the causes of infertility and considering individual patient concerns. 

Owing to its massive investments in health care administration, expanding human population and increasing infertility cases, the Asia-Pacific region is the kingpin of the global assisted reproductive technology market. Countries such as China and India are in need of assisted reproductive technologies (ART) because of changing social norms, rising awareness levels and easier access to modern reproductive technology. The region also gains from increased government funding, changing laws and policies, and an increase in fertility clinics providing state-of-the-art care. These elements coming together, combined with enhanced healthcare systems and economic growth, puts Asia-Pacific as a prominent market for ART, spurring its innovation and growth. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Assisted reproductive technology Market

Report ID: SQMIG35G2228

$5,300
BUY NOW GET FREE SAMPLE